Answers are grounded in this paper and cite their sources.
Surveillance study finds no significant increase in serious adverse outcomes in vaccinated individuals, indicating a reassuring initial safety profile.
In interim analyses of surveillance of mRNA COVID-19 vaccines, incidence of selected serious outcomes was not significantly higher 1 to 21 days postvaccination compared with 22 to 42 days postvaccination. While CIs were wide for many outcomes, surveillance is ongoing.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: